Abstract
The aim of designing this consensus document was to collaborate with nephrologists in the management of mineral metabolism in in patients with chronic kidney disease. To do this, we formulated questions requiring answers for the clinical management of our patients and consulted bibliographic sources and international guidelines with the aim of adapting them to the Argentine situation. The new definitions and the more integrated classification system recently proposed by the Kidney Disease Improving Global Outcomes (KDIGO) Foundation have been taken into account. Chapter V on the Treatment of Abnormal Parathyroid Hormone Values in patients with Stage 5 Chronic Kidney Disease is presented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
